Vaccines

Latest News


Latest Videos


Shorts

Vaccines vs. Monoclonal Antibodies: Understanding the Key Distinction
0:53
Vaccines vs. Monoclonal Antibodies: Understanding the Key Distinction
4 months ago
by
Logan Lutton

CME Content


More News

A CDC-led test-negative case-control study using the VISION network found that the 2024-2025 COVID-19 vaccine reduced the odds of medically attended COVID-19 in adults, with an effectiveness of 26% against emergency department/urgent care encounters, 35% against hospitalization and 41% against critical illness, benefits that held up in older adults and immunocompromised patients but waned over time since vaccination.